Last updated on February 2013

A Phase 1 Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Brief description of study

The primary objective of this study is to evaluate the safety and tolerability of MEDI-551 in Japanese patients with relapsed or refractory advanced B-cell malignancies.

Clinical Study Identifier: NCT01377116

Find a site near you

Start Over

Research site

Nagoya-shi, Japan
  Connect »